Plus Therapeutics Presents at the Sixth Biennial Pediatric Neuro-Oncology Research Conference (GlobeNewswire) - Jun 10, 2021 - "Plus Therapeutics...announced it will present a poster at the 6th Biennial Pediatric Neuro-Oncology Research Conference hosted by the Society for Neuro-Oncology (SNO), being held virtually June 10-12, 2021. The poster presentation is titled, ‘A two-part, Phase I study of Rhenium-186 Nanoliposomes (186RNL) delivered by convection enhanced delivery (CED) for recurrent, refractory, or progressive ependymoma and high-grade glioma (HGG)'...Presented data include a review of relevant preclinical research, the company's Phase 1 ReSPECTTM clinical trial in recurrent glioblastoma (GBM) and a proposed design for initiating a Phase I clinical trial in pediatric brain tumors."
P1 data • Brain Cancer • CNS Tumor • Glioblastoma • Glioma • Oncology
|